Invesco S&P MidCap Momentum ETF (XMMO) is rated a buy with a $170 price target, implying 20% upside for 2026. XMMO is positioned to benefit from Fed rate cuts, robust US GDP growth, and strong earnings momentum in mid-cap stocks. XMMO's portfolio is diversified across sectors, led by high-growth holdings like CIEN, TWLO, and LITE, supporting the bullish outlook.

It's been a strong year for US stocks, with the top-performing S&P 500 companies delivering remarkable gains fueled by AI-driven demand, commodity surges, and domestic manufacturing and trade policy tailwinds. The storage and memory sector, including SanDisk, Western Digital, Seagate, and Micron, was among the year's top performers due to increased investment in AI hardware.

Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) has agreed to acquire Manus, a Singapore-based artificial intelligence company with Chinese roots, in a deal valued at more than $2 billion, Bloomberg reported on Tuesday. According to the report, the acquisition, completed in roughly 10 days, marks a rare US purchase of an Asian tech company.

Service Properties Trust (SVC) is transitioning from a hotel-focused REIT to a predominantly net lease REIT, unlocking valuation upside. SVC has executed significant hotel asset sales, reduced debt, and now boasts robust liquidity exceeding $1 billion. The current 10x EBITDA multiple undervalues SVC relative to net lease peers, suggesting 30–40% share price upside.

With consumer confidence sliding, low-beta defensive picks like ATO, AWR, SRE and INGR stand out as investors look to limit downside risk.

Kontoor Brands (KTB) may prove to be a promising addition to your investment portfolio, as it demonstrates a high cash yield, solid fundamentals, and a favorable valuation. Companies of this nature can utilize cash to support further revenue growth or distribute it to their shareholders through dividends or buyback programs.

LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Blue Owl Capital Inc. (“Blue Owl” or “the Company”) (NYSE: OWL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 2, 2026.

San Antonio, TX, Dec. 30, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the "Company"), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, is proud to celebrate two significant milestones on December 30, 2025. In a year marked by historic moves in gold, the U.S. Global GO GOLD and Precious Metals Miner ETF (GOAU) will transition from passive indexing to active management, enabling greater agility while remaining grounded in the Company's proprietary Smart Beta 2.0 investment discipline.

LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Inspire Medical (“Inspire” or the "Company") (NYSE: INSP) investors of a class action on behalf of investors that bought securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.

Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced that on December 23, 2025, it entered into an agreement (the “Agreement”) with an unrelated third party, Wei Ha Hui (the “Buyer”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “Hong Kong Subsidiary”), for an aggregate purchase price …

DLTR's store conversions, 3.0 formats and Uber Eats partnership lift comps, traffic and basket size, signaling sustainable growth momentum.

Automatic Data Processing accelerates growth via DataCloud, Q1 FY26 mid-single-digit gains and 25.5% margins, plus smart deals and a 51st straight dividend hike.

Toronto-Dominion (TD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Fox (FOX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Micron (MU) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Hagerty (HGTY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Jones Lang LaSalle (JLL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Chicago, Dec. 30, 2025 (GLOBE NEWSWIRE) -- In 2025, Christie's International Real Estate strengthened its stature as the global authority in luxury real estate, welcoming a wave of premier affiliates across the Americas, Europe, and Asia-Pacific, closing industry-defining sales, and attracting a number of top-producing agents. These accomplishments underscore the enduring value of a brand built on global reach, local expertise and a bespoke client experience, and position the network for a successful 2026.

LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the "Company") (NASDAQ: TLX) investors of a class action on behalf of investors that bought securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2026 to file a lead plaintiff motion.

LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Coupang, Inc., (“Coupang” or the "Company") (NYSE: CPNG) investors off a class action on behalf of investors that bought securities between August 6, 2025 and December 16, 2025, inclusive (the “Class Period”). Coupang investors have until February 17, 2026 to file a lead plaintiff motion.